Insider trades

King-Jones Heidy

King-Jones Heidy made 0 buys and 10 sales on the open market in the last 12 months at Spyre Therapeutics, Inc. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Oct 1, 2026Spyre Therapeutics, Inc.Sale400US$89
Oct 1, 2026Spyre Therapeutics, Inc.Sale16,605US$90
Oct 1, 2026Spyre Therapeutics, Inc.Sale7,228US$91
Oct 1, 2026Spyre Therapeutics, Inc.Sale2,100US$93
Oct 1, 2026Spyre Therapeutics, Inc.Sale2,600US$93
Sep 2, 2026Spyre Therapeutics, Inc.Sale400US$90
Sep 1, 2026Spyre Therapeutics, Inc.Sale4,845US$86
Sep 1, 2026Spyre Therapeutics, Inc.Sale16,548US$87
Sep 1, 2026Spyre Therapeutics, Inc.Sale6,206US$88
Sep 1, 2026Spyre Therapeutics, Inc.Sale400US$89